Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics

Widespread application of omic technologies is evolving our understanding of population health and holds promise in providing precise guidance for selection of therapeutic interventions based on patient biology. The opportunity to use hundreds of analytes for diagnostic assessment of human health co...

Full description

Bibliographic Details
Published in:	Metabolites
Main Authors:	Vladimir Tolstikov, A. James Moser, Rangaprasad Sarangarajan, Niven R. Narain, Michael A. Kiebish
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Subjects:	metabolomics biomarker demographics clinical phenotype discovery
Online Access:	https://www.mdpi.com/2218-1989/10/6/224

Similar Items

Integrated Metabolomics Assessment of Human Dried Blood Spots and Urine Strips
by: Jeremy Drolet, et al.
Published: (2017-07-01)

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification
by: Chunsheng Lin, et al.
Published: (2024-05-01)

Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine
by: Rosa Perestrelo, et al.
Published: (2025-06-01)

Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma
by: Daniel A. Mohl, et al.
Published: (2023-04-01)

Metabolomics in drug discovery: Restoring antibiotic pipeline
by: Faiza Azhar, et al.
Published: (2023-01-01)

Optimising Extracellular Vesicle Metabolomic Methodology for Prostate Cancer Biomarker Discovery
by: Mahmoud Assem Hamed, et al.
Published: (2024-06-01)

A Fecal-Microbial-Extracellular-Vesicles-Based Metabolomics Machine Learning Framework and Biomarker Discovery for Predicting Colorectal Cancer Patients
by: Fatma Hilal Yagin, et al.
Published: (2023-04-01)

Machine Learning-Driven Insights in Cancer Metabolomics: From Subtyping to Biomarker Discovery and Prognostic Modeling
by: Amr Elguoshy, et al.
Published: (2025-08-01)

Plant Metabolomics: The Future of Anticancer Drug Discovery
by: Ranin Dabbousy, et al.
Published: (2024-09-01)

Simultaneous Quantitation and Discovery (SQUAD) Analysis: Combining the Best of Targeted and Untargeted Mass Spectrometry-Based Metabolomics
by: Bashar Amer, et al.
Published: (2023-05-01)

Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects
by: S. Rischke, et al.
Published: (2023-04-01)

Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis
by: Rasanpreet Kaur, et al.
Published: (2024-12-01)

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
by: Nuria Gómez-Cebrián, et al.
Published: (2019-03-01)

Application of Metabolomics in Pediatric Asthma: Prediction, Diagnosis and Personalized Treatment
by: Maria Michelle Papamichael, et al.
Published: (2021-04-01)

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
by: Alessia Vignoli, et al.
Published: (2023-08-01)

Biomarker discovery for tuberculosis using metabolomics
by: Yi Yu, et al.
Published: (2023-02-01)

The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment
by: Mohammad Alwahsh, et al.
Published: (2024-08-01)

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
by: Sarah Shigdar, et al.
Published: (2021-12-01)

Application of Metabolomics and the Discovery of Potential Serum Biomarkers for Diuretic Resistance in Heart Failure
by: Yipin Yu, et al.
Published: (2025-04-01)

Using Literature Based Discovery to Gain Insights Into the Metabolomic Processes of Cardiac Arrest
by: Sam Henry, et al.
Published: (2021-06-01)

Discovering Hair Biomarkers of Alzheimer’s Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics
by: Yu-Hsiang Su, et al.
Published: (2023-02-01)

Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery
by: Song Q, et al.
Published: (2023-11-01)

From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma
by: Neja Šamec, et al.
Published: (2025-04-01)

Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach
by: Jacopo Troisi, et al.
Published: (2020-10-01)

Utilizing the Food–Pathogen Metabolome to Putatively Identify Biomarkers for the Detection of Shiga Toxin-Producing <i>E. coli</i> (STEC) from Spinach
by: Snehal R. Jadhav, et al.
Published: (2021-01-01)

Metabolomics: An Emerging “Omics” Platform for Systems Biology and Its Implications for Huntington Disease Research
by: Sumeyya Akyol, et al.
Published: (2023-12-01)

A two-stage metabolome refining pipeline for natural products discovery
by: Ran Zhang, et al.
Published: (2025-06-01)

Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy
by: Xiaohui Du, et al.
Published: (2022-10-01)

Discovery and Validation of Novel Biomarkers for Colorectal Neoplasia Detection via Plasma Metabolomics
by: Jianv Huang, et al.
Published: (2025-06-01)

Metabolomic biomarkers discovery across chronic gastritis to gastric cancer progression
by: Le Yang, et al.
Published: (2025-09-01)

Infection Biomarkers Based on Metabolomics
by: Rúben Araújo, et al.
Published: (2022-01-01)

The application of Aptamer in biomarker discovery
by: Yongshu Li, et al.
Published: (2023-07-01)

Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition
by: Mohamad Saoud, et al.
Published: (2024-12-01)

Editorial: Metabolomics perspectives for clinical medicine, volume II
by: Danuta Dudzik, et al.
Published: (2025-03-01)

Diagnosis of preeclampsia using metabolomic biomarkers
by: Yunfan Tian, et al.
Published: (2024-12-01)

The characterization of serum proteomics and metabolomics across the cancer trajectory in chronic hepatitis B‐related liver diseases
by: Jin Xiao, et al.
Published: (2024-12-01)

Deep learning-based metabolomics data study of prostate cancer
by: Liqiang Sun, et al.
Published: (2024-12-01)

Metabolomics insights into Charcot–Marie–Tooth disease: toward biomarker discovery
by: Signe Setlere, et al.
Published: (2025-05-01)

LC-MS-Based Metabolomics for Dietary Biomarker Discovery in a Cohort of Pregnant and Lactating Women and Their Infants
by: Mia Stråvik, et al.
Published: (2023-11-01)

Discovery of Urinary Biomarkers of Seaweed Intake Using Untargeted LC–MS Metabolomics in a Three-Way Cross-Over Human Study
by: Muyao Xi, et al.
Published: (2020-12-01)